HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemia.

Toulemonde C, Dubois V, Bouvier C, Ridao A, Archier MC, Balsat M, Ducastelle S, Barraco F, Fossard G, Hildt J, Bollard J, Michallet M, Labussière-Wallet H, Hayette S, Nicolini FE, Alcazer V.

Open source

DOI
10.1002/hem3.70261
Published
2025-11-14
Container
Hemasphere
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70261,
  title = {HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemia.},
  author = {Toulemonde C and  Dubois V and  Bouvier C and  Ridao A and  Archier MC and  Balsat M and  Ducastelle S and  Barraco F and  Fossard G and  Hildt J and  Bollard J and  Michallet M and  Labussière-Wallet H and  Hayette S and  Nicolini FE and  Alcazer V.},
  year = {2025},
  journal = {Hemasphere},
  doi = {10.1002/hem3.70261},
  url = {https://doi.org/10.1002/hem3.70261}
}

RIS

TY  - JOUR
TI  - HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemia.
AU  - Toulemonde C
AU  -  Dubois V
AU  -  Bouvier C
AU  -  Ridao A
AU  -  Archier MC
AU  -  Balsat M
AU  -  Ducastelle S
AU  -  Barraco F
AU  -  Fossard G
AU  -  Hildt J
AU  -  Bollard J
AU  -  Michallet M
AU  -  Labussière-Wallet H
AU  -  Hayette S
AU  -  Nicolini FE
AU  -  Alcazer V.
PY  - 2025
JO  - Hemasphere
DO  - 10.1002/hem3.70261
UR  - https://doi.org/10.1002/hem3.70261
ER  - 

APA

C, T., V, D., C, B., A, R., MC, A., M, B., S, D., F, B., G, F., J, H., J, B., M, M., H, L., S, H., FE, N., & V., A. (2025). HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemia.. Hemasphere. https://doi.org/10.1002/hem3.70261

Source records